BRENDA MAH-MCCAA
Allopathic & Osteopathic Physicians|Family Medicine HUNTINGTON BEACH, CA NPI 1023022993
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine CA Axsome Therapeutics, Inc. All categories
General Payments — all program years on this page
$285.07
- Category: General Payments
- Program years: PY2023–2024
- Record count: 14
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $185.93 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $185.93 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Axsome Therapeutics, Inc. | $57.56 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.54 | 1 |
| ABBVIE INC. | $26.19 | 1 |
| Novo Nordisk AS | $19.68 | 1 |
| Janssen Pharmaceuticals, Inc | $18.15 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.30 | 1 |
| Acerta Pharma LLC | $16.51 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1077925863 | Janssen Pharmaceuticals, Inc | $18.15 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086212177 | Bayer Healthcare Pharmaceuticals Inc. | $17.30 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096610558 | Novo Nordisk Inc | $19.68 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104925675 | ABBVIE INC. | $26.19 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105295554 | AstraZeneca Pharmaceuticals LP | $16.51 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137627397 | Takeda Pharmaceuticals U.S.A., Inc. | $30.54 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148268362 | Axsome Therapeutics, Inc. | $29.61 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148268364 | Axsome Therapeutics, Inc. | $27.95 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.